Patient Education for Individuals Starting Ozempic (Semaglutide)
Patients starting Ozempic should receive comprehensive education on dose titration, common side effects (particularly gastrointestinal), monitoring requirements, and potential drug interactions to maximize treatment success and minimize adverse effects.
Dosing and Administration Instructions
Dose Titration Schedule:
- Semaglutide should be started at 0.25 mg weekly for the first 4 weeks
- Then increased to 0.5 mg weekly for weeks 5-8
- Further increased to 1.0 mg weekly for weeks 9-12
- Then to 1.7 mg weekly for weeks 13-16
- Finally reaching the maintenance dose of 2.4 mg weekly after 16 weeks 1
Administration Technique:
- Inject subcutaneously once weekly on the same day each week
- Injection can be given regardless of meal timing
- Rotate injection sites (abdomen, thigh, or upper arm)
- Never reuse or share needles with others 2
Managing Common Side Effects
- Gastrointestinal Side Effects:
- Inform patients that nausea (40%), vomiting (16%), diarrhea, and constipation are the most common side effects 1
- These effects are typically most pronounced during dose escalation and often improve over time
- For nausea/vomiting: suggest smaller, more frequent meals and avoiding high-fat foods
- For diarrhea: recommend adequate hydration and over-the-counter medications like loperamide if needed
- For constipation: advise increased fluid intake and dietary fiber 1, 2
Monitoring Requirements
Blood Glucose Monitoring:
Regular Follow-up:
- Monthly visits for the first 3 months, then quarterly
- Laboratory monitoring should include periodic assessment of renal function 2
Potential Drug Interactions and Precautions
Medication Interactions:
- Ozempic should not be used with other GLP-1 receptor agonists or DPP-4 inhibitors
- Caution with insulin or sulfonylureas - dose reductions may be necessary to prevent hypoglycemia
- Time-sensitive medications should be taken at least 1 hour before Ozempic injection due to delayed gastric emptying 1
Warning Signs Requiring Medical Attention:
- Severe abdominal pain (possible pancreatitis) - stop using and seek immediate medical attention
- Signs of allergic reactions (rash, itching, difficulty breathing)
- Symptoms of hypoglycemia (dizziness, sweating, confusion)
- Changes in vision
- Signs of dehydration or kidney problems 2
Special Populations and Contraindications
Contraindications:
- Personal or family history of medullary thyroid carcinoma
- Multiple endocrine neoplasia syndrome type 2
- Pregnancy and breastfeeding 2
Women of Reproductive Potential:
- Must use reliable contraception while on Ozempic 2
Storage and Handling
- Storage Instructions:
- Unused pens: refrigerate between 36°F to 46°F (2°C to 8°C)
- Pen in use: can be stored at room temperature between 59°F to 86°F (15°C to 30°C) or in refrigerator
- Discard pen after 56 days, even if medication remains
- Do not freeze Ozempic 2
Expectations and Treatment Goals
Weight Loss Expectations:
- Significant weight reduction is common (3-7 kg on average)
- Weight loss typically continues for several months 1
Glycemic Control:
- HbA1c reductions of 1.2-1.6% can be expected
- Full benefits may take several weeks to develop 1
Common Pitfalls to Avoid
Premature Discontinuation:
- Many patients stop treatment due to early GI side effects - emphasize that these typically improve with time
- If side effects are severe, consider slowing the dose escalation rather than stopping completely 1
Missed Doses:
- If 1-2 consecutive doses are missed, resume at the same dose if well-tolerated
- If 3+ consecutive doses are missed, consider restarting the titration schedule 1
Dehydration Risk:
- GI side effects may lead to dehydration, which can worsen kidney function
- Emphasize importance of adequate fluid intake, especially if experiencing nausea, vomiting, or diarrhea 2
Patient education is crucial for successful treatment with Ozempic, as proper understanding of administration, side effect management, and monitoring requirements significantly improves adherence and outcomes.